145 related articles for article (PubMed ID: 9056412)
21. Matrix-degrading metalloproteinases in tumor progression.
Matrisian LM; Wright J; Newell K; Witty JP
Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
[TBL] [Abstract][Full Text] [Related]
22. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer.
Impola U; Uitto VJ; Hietanen J; Hakkinen L; Zhang L; Larjava H; Isaka K; Saarialho-Kere U
J Pathol; 2004 Jan; 202(1):14-22. PubMed ID: 14694517
[TBL] [Abstract][Full Text] [Related]
24. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
[TBL] [Abstract][Full Text] [Related]
25. Extracellular matrix production and degradation by adenoid cystic carcinoma cells: participation of plasminogen activator and its inhibitor in matrix degradation.
Shirasuna K; Saka M; Hayashido Y; Yoshioka H; Sugiura T; Matsuya T
Cancer Res; 1993 Jan; 53(1):147-52. PubMed ID: 8380125
[TBL] [Abstract][Full Text] [Related]
26. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
27. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
[TBL] [Abstract][Full Text] [Related]
28. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase.
Kataoka H; DeCastro R; Zucker S; Biswas C
Cancer Res; 1993 Jul; 53(13):3154-8. PubMed ID: 8319225
[TBL] [Abstract][Full Text] [Related]
29. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome.
Kerkelä E; Ala-aho R; Klemi P; Grénman S; Shapiro SD; Kähäri VM; Saarialho-Kere U
J Pathol; 2002 Oct; 198(2):258-69. PubMed ID: 12237887
[TBL] [Abstract][Full Text] [Related]
30. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
Meade-Tollin LC; Way D; Witte MH
Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin degradation by human gastric carcinoma cell lines and its associated proteases in relation to stromal invasion in nude mice.
Wakabayashi H; Kawaguchi T
Invasion Metastasis; 1992; 12(5-6):284-300. PubMed ID: 1298740
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis.
Tsukifuji R; Tagawa K; Hatamochi A; Shinkai H
Br J Cancer; 1999 Jun; 80(7):1087-91. PubMed ID: 10362121
[TBL] [Abstract][Full Text] [Related]
33. Activation of fibroblast collagenase-1 expression by tumor cells of squamous cell carcinomas is mediated by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase-2.
Westermarck J; Li S; Jaakkola P; Kallunki T; Grénman R; Kähäri VM
Cancer Res; 2000 Dec; 60(24):7156-62. PubMed ID: 11156425
[TBL] [Abstract][Full Text] [Related]
34. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
[TBL] [Abstract][Full Text] [Related]
35. Regulation of collagenase, stromelysin, and urokinase-type plasminogen activator in primary pterygium body fibroblasts by inflammatory cytokines.
Solomon A; Li DQ; Lee SB; Tseng SC
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2154-63. PubMed ID: 10892857
[TBL] [Abstract][Full Text] [Related]
36. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
37. Differential protease expression by cutaneous squamous and basal cell carcinomas.
Sappino AP; Belin D; Huarte J; Hirschel-Scholz S; Saurat JH; Vassalli JD
J Clin Invest; 1991 Oct; 88(4):1073-9. PubMed ID: 1918364
[TBL] [Abstract][Full Text] [Related]
38. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
[TBL] [Abstract][Full Text] [Related]
39. PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression.
Luparello C; Sirchia R; Pupello D
J Cell Sci; 2003 Jun; 116(Pt 12):2421-30. PubMed ID: 12724357
[TBL] [Abstract][Full Text] [Related]
40. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice.
Powell WC; Knox JD; Navre M; Grogan TM; Kittelson J; Nagle RB; Bowden GT
Cancer Res; 1993 Jan; 53(2):417-22. PubMed ID: 8417833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
